GSK
GSK plc
Stock
$47.03−0.15 (−0.32%)Close Oct 2, 2026
- EBITDA, FY2025
- £10.2B
- YoY, FY2025
- +55.9%
- 5-year CAGR
- +5.0%
- 10-year CAGR
- −1.5%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| FY2025 | £10.2B | +55.9% |
| FY2024 | £6.6B | −27.3% |
| FY2023 | £9.0B | +5.3% |
| FY2022 | £8.6B | +32.4% |
| FY2021 | £6.5B | −19.3% |
| FY2020 | £8.0B | −13.6% |
| FY2019 | £9.3B | +26.7% |
| FY2018 | £7.3B | +22.1% |
| FY2017 | £6.0B | +37.4% |
| FY2016 | £4.4B | −63.4% |
| FY2015 | £12.0B | — |